Yuna Park

14PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsObstetrics and gynaecologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 05, 2025
Boosting tumor homing of endogenous natural killer cells via therapeutic secretomes of chemically primed natural killer cells.

Seohyun Cho, Seung Hee Choi, Eunchong Maeng

|Jul 08, 2023
The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics.

Joo Dong Park, Hye Jung Jang, Seung Hee Choi

|Oct 28, 2022
ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer.

Jihee Lee, Kyoungwha Pang, Junil Kim

|Aug 26, 2022
Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy.

Seung Hee Choi, Hye Jin Kim, Joo Dong Park

|Jul 20, 2022
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics.

Joo Dong Park, Kwang-Soo Kim, Seung Hee Choi

|Jul 08, 2022
Mast4 determines the cell fate of MSCs for bone and cartilage development.

Pyunggang Kim, Jinah Park, Dong-Joon Lee

Pageof 3

Frequent Collaborators

4 joint publications

Kyoungwha Pang

3 joint publications

Joo Dong Park

3 joint publications

Seung Hee Choi

3 joint publications

Youngjin Han